Krka reports record-high sales revenue and profit

Ljubljana, 16 May - The pharmaceutical group Krka generated EUR 486.1 million in sales revenue in the first three months of the year, an increase of 6% over the same period last year, while its net profit increased by 11% to EUR 98.8 million, the core company said on Thursday, adding that the figures are record-high.